When publications lead to products: The open science conundrum in new product development

Jong, Simcha; Slavova, Kremena

doi:10.1016/j.respol.2013.12.009

Cited by 67 publications

(66 citation statements)

References 72 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is evidence here, therefore, to support Jong (2008) and Jong and Slavova (2014) that organizational behavior and academics' links with industry vary by academic experience and by place. In Oxfordshire and Zurich, this is also related to varying levels of research funding and supply of graduates.…”

Section: Discussionsupporting

confidence: 53%

“…However, organizational behavior and academic links with industry vary by academic experience and by place (Jong 2008, 2012& Jong and Slavova 2014. Jong (2008) finds differences in the behavior of therapeutic biotech firms in Cambridge and The section below presents the description of the data used to compare the two example regions: Oxfordshire and Zurich.…”

Section: The Organizational Levelmentioning

confidence: 99%

See 1 more Smart Citation

Innovation capacity in the healthcare sector and historical anchors: examples from the UK, Switzerland and the US

2015

View full text Add to dashboard Cite

Acknowledgements: we thank John Slater for his comments on an earlier version of this paper. Laurel Edmunds is supported by the NIHR Oxford BRC Innovation is an integral part of economic development in developed economies. In the post 2008 period, a key policy agenda is that of sustainable development, which calls for innovation in all aspects of value-chains. In this paper, we focus on innovation from the biotech -pharma perspective to see whether or not this will lead to a sustainable future for the regions where there are clusters of firms in this sector. We examine data from a recently completed European Union study of innovation in the Healthcare sector from the UK and Switzerland, countries with an historical base in pharma, to understand how innovation pathways vary at the regional level in the broader life sciences, which incorporate biotech and more. Innovation in the healthcare sector in two regions, Oxfordshire in the UK and Zurich in Switzerland are compared. We contextualize our discussion by drawing on studies that focus on the sector in the United States, specifically Boston. The analytical framework comprises three elements: innovation systems and national and regional economic development theories are the first two, followed by approaches which consider organizational or institutional activity. This framework is used to help explain and understand the complexity of how innovation is organized at the sub-national level. The overall context is that it is increasing becoming a condition for government financing of research that it has more immediate application in industry or have the possibility of commercialisation (e.g., translational research).

show abstract

Section: Discussionsupporting

confidence: 53%

Section: The Organizational Levelmentioning

confidence: 99%

Innovation capacity in the healthcare sector and historical anchors: examples from the UK, Switzerland and the US

2015

View full text Add to dashboard Cite

show abstract

“…On Grand et al 2012;Gowers and Nielsen 2009;Haeussler 2011;Jong and Slavova 2014;Lievrouw 2010;Meyer and Schroeder 2013;Mukherjee and Stern 2009;Neylon and Wu 2009;Nielsen 2012;Procter et al 2010;Scheliga and Friesike 2014;Tacke 2010;Waldrop 2008), and open innovation (e.g., Chesbrough 2003aChesbrough , 2003bChesbrough , 2006Dahlander and Gann, 2010;van de Vrande et al 2010).…”

Section: Perspectives Of Open Sciencementioning

confidence: 99%

“…Yet, the very early stages of research and science have hardly been analyzed by the current open innovation literature. In other words, we currently experience a vibrant debate within scientific theory that focuses on open science (Bartling and Friesike 2014;Jong and Slavova 2014). Yet, this debate mostly neglects its interdependency to innovation.…”

Section: Introductionmentioning

confidence: 99%

Opening science: towards an agenda of open science in academia and industry

Widenmayer²,

et al. 2014

View full text Add to dashboard Cite

The shift towards open innovation has substantially changed the academic and practical understanding of corporate innovation. While academic studies on open innovation are burgeoning, most research on the topic focuses on the later phases of the innovation process. So far, the impact and implications of the general tendency towards more openness in academic and industrial science at the very front-end of the innovation process have been mostly neglected. Our paper presents a conceptualization of this open science as a new research paradigm. Based on empirical data and current literature, we analyze the phenomenon and propose four perspectives of open science. Furthermore, we outline current trends and propose directions for future developments.

show abstract

“…Finally, scientific articles are an important channel for communicating findings to stakeholders. This is especially the case for informing financial markets, as publishing is a signal of scientific competences to external stakeholders and increases beliefs about future profitability (Jong and Slavova 2014;Polidoro & Theeke 2012). Hicks (1995) argues that "journal articles performance with respect to ZnSe (Johnstone, 2007).…”

mentioning

confidence: 99%

Changing of the Guard: Structural Change and Corporate Science in the Semiconductor Industry

Pellens

Malva

2016

SSRN Journal

View full text Add to dashboard Cite

Die Dis cus si on Pape rs die nen einer mög lichst schnel len Ver brei tung von neue ren For schungs arbei ten des ZEW. Die Bei trä ge lie gen in allei ni ger Ver ant wor tung der Auto ren und stel len nicht not wen di ger wei se die Mei nung des ZEW dar.Dis cus si on Papers are inten ded to make results of ZEW research prompt ly avai la ble to other eco no mists in order to encou ra ge dis cus si on and sug gesti ons for revi si ons. The aut hors are sole ly respon si ble for the con tents which do not neces sa ri ly repre sent the opi ni on of the ZEW. AbstractThis article documents a structural change in the production of science in the U.S. semiconductor industry over almost three decades. We observe a change in scientific productivity over time, where smaller firms publish more articles per dollar in R&D. Moreover, our results show a positive relationship between the value of intangibles and scientific publications, driven by basic research results. These effects are especially strong among Fabless 'design' firms and among firms in the post-PC era of semiconductor manufacturing, in line with a premium for smaller firms which invest in science in times of structural technological change. JEL-Classification: O31, O33

show abstract

When publications lead to products: The open science conundrum in new product development

Cited by 67 publications

References 72 publications

Innovation capacity in the healthcare sector and historical anchors: examples from the UK, Switzerland and the US

Innovation capacity in the healthcare sector and historical anchors: examples from the UK, Switzerland and the US

Opening science: towards an agenda of open science in academia and industry

Changing of the Guard: Structural Change and Corporate Science in the Semiconductor Industry

Contact Info

Product

Resources

About